Screw implant apparatus and method

Information

  • Patent Application
  • 20070287129
  • Publication Number
    20070287129
  • Date Filed
    April 23, 2007
    17 years ago
  • Date Published
    December 13, 2007
    17 years ago
Abstract
An enossal screw implant is inserted cortically into the jawbone as an implant base and a mount for the superstructure of a tooth replacement or a substructure. A break point is provided in the abutment head above a bending zone. Key surfaces are above and below the break point. Solutions to ease adjustment of the inserted implant to the natural tooth position and which can reduce the danger of loosening of the inserted implant in the jawbone are coated on the implant.
Description

BRIEF DESCRIPTION OF THE DRAWINGS

The present invention will become more fully understood from the detailed description and the accompanying drawings, wherein:



FIG. 1 is an overall view of the screw implant according to the invention.



FIG. 2 is a plan view on the head surface of the implant.



FIG. 3 is an advantageous profile cross-section in the neck region with an established bending line.





DEPICTED COMPONENTS INCLUDE





    • (1) Screw implant;

    • (2) Abutment;

    • (3) Abutment head;

    • (4) Predetermined breaking point;

    • (5) Cylindrical foot section;

    • (6) Conical foot section;

    • (7) Terminal section;

    • (8) Neck section;

    • (9) Wrench flats;

    • (10) Head surface;

    • (11) Mark;

    • (12) Profile cross-section in the bending zone;

    • (13) Bar;

    • (14) Sawtooth profile;

    • (15) Second predetermined breaking point;

    • (16) Thread; and

    • (17) Bending line.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The following description of the preferred embodiment(s) is merely exemplary in nature and is in no way intended to limit the invention, its application, or uses.


The screw implant 1 according to the invention is preferably provided with an abutment 2, and has a break point 4 with a reduced profile cross-section in the vicinity of the abutment head 3. The profile cross-section of this break point 4 is chosen so that any break that can be caused, for example, by occurrence of elevated torque on inserting the screw implant 1 occurs at this break point 4, before a break occurs in the vicinity of the bendable neck section 8 with a reduced profile cross section.


The break point 4 is preferably in the vicinity of the key surfaces 9 which accept a suitable tool for screwing in the screw implant 1. The break point 4 is arranged so that the key surfaces 9 extending from the head area 10 of the abutment head continue below the break point 4 and end between the bendable neck section 8 and the break point 4.


In case of a break, the insertion tool can be placed on the remaining key surfaces 9 below the break point 4 and the broken screw implant 1 can be unscrewed out of the implant bed in a relatively simple way.


The reduced profile cross-section of the bendable neck section 8 forms a bending zone with a previously established bending line, which is marked on the head surface of the implant and is determined by the selected profile in the bending zone. According to the present invention, the bending zone has an elliptical profile or the form of a bar 13, which can, for example, be produced by milling. The longitudinal axes of this profile form the bending lines 10; 11, which are indicated by the mark 9 in the head surface 8, indicating the preferred direction of bending for subsequent bending operations, in which the danger of breakage of the profile cross-section in the bending zone is a minimum because of the design of the profile cross-section according to the invention.


The implant base that is to be held by the jawbone is formed of a foot section which consists of a cylindrical foot segment 5 and a conical foot segment 6. As a deviant from the design shown, the foot section can also be made up of an over-all conical foot section 6. Both the cylindrical and the conical foot sections are provided with a thread 16 for screwing the implant 1 into the jawbone.


The implant base ends at an end section 7, which connects to the conical foot section through a breakpoint 15 and which can, if necessary, be separated from the remaining body of implant 1 at breakpoint 15.


The enossal surface of the implant is preferably provided with a microporous surface structure by known processes, and after cleaning of the implant, an adherent water-soluble or fat-soluble ibandronate solution is also applied, so that the active substance occurs at a dosage of 3 to 8 mg in the coating on the enossal surface of the implant.


In the absence of the microporous surface structure, the adherent water-soluble or fat-soluble ibandronate solution of the stated dosage can also be applied directly onto the enossal surface of the implant. This coating is preferably applied to the enossal surface immediately before insertion of the implant, and the implant is inserted into the prepared cavity after the applied coating has dried.


As various modifications could be made to the exemplary embodiments, as described above with reference to the corresponding illustrations, without departing from the scope of the invention, it is intended that all matter contained in the foregoing description and shown in the accompanying drawings shall be interpreted as illustrative rather than limiting. Thus, the breadth and scope of the present invention should not be limited by any of the above-described exemplary embodiments, but should be defined only in accordance with the following claims appended hereto and their equivalents.

Claims
  • 1. A bone implant comprising: a foot section,a neck section, said neck section being connected to said foot section, and said neck section having a bending zone,an abutment connected to the neck section in a one-piece form to mount a tooth replacement,said abutment head having a break point.
  • 2. Screw implant according to claim 1, characterized in that the diameter of the profile cross-section at the break point is less than the minimum thickness in the bending zone of the neck section.
  • 3. Screw implant according to claim 1, characterized in that key surfaces are provided below the break point.
  • 4. Screw implant according to claim 3, wherein said key surfaces end between the break point and the neck section.
  • 5. Screw implant according to claim 1, characterized in that the bending zone has an elliptical, oval-shaped profile cross-section with a predetermined bending line, with the minimum diameter in the profile cross-section being smaller than the largest diameter of the thread.
  • 6. Screw implant according to claim 1, characterized in that an orientation of the bending zone is indicated by a mark on the head surface of the implant.
  • 7. Screw implant according to claim 1 wherein a foot section consisting of a cylindrical foot section and a conical foot section connected, said cylindrical foot section being connected to the bending zone.
  • 8. Screw implant according to claim 1 characterized in that at least one of the cylindrical foot section or the conical foot section are provided with a thread.
  • 9. Screw implant according to claim 1 characterized in that a terminal section is separably connected with the foot section through a second break point.
  • 10. Screw implant according to claim 1 characterized in that said foot section has a threaded portion and a sawtooth portion.
  • 11. Screw implant according to claim 1 characterized in that the foot section is a conical foot section.
  • 12. Screw implant according to claim 1 characterized in that the profile cross-section at the bending zone is selected from the group consisting of a bar and an elliptical shape and the longitudinal axis of the ellipse is the predetermined bending line.
  • 13. A bone implant comprising: a foot section;a neck section, said neck section being connected to said foot section, and said neck section having a bending zone;an abutment connected to the neck section in a one-piece form to mount a tooth replacement anda coating, said coating including ingredients which delay osteonal remodeling of the jaw bone in the vicinity of the implantation osteotomy, is applied onto enossal surfaces of the implant.
  • 14. The implant according to claim 13, characterized in that the active substance in the coating is a bisphosphonate.
  • 15. The implant of claim 13 wherein the coating contains an adherent water-soluble or fat soluble ibandronate solution.
  • 16. The implant of claim 15 wherein said ibandronate is selected from the group consisting of an etidronate, a clodronate, a tiludronate, a pamidronate, an alendronate, a risedronate, an ibandronate, a zoledronate or a combination of them as the active substance.
  • 17. The implant according to claim 13 characterized in that the active substance in the coating is selected from the group of estrogens.
  • 18. The implant of claim 13 wherein the coating contains TGF-beta, gallium nitrate, plicamycin, calcitriol, calcetonin, bafilomycin or combinations of them as the active substance.
  • 19. The implant according to claim 13 characterized in that the active substance in the coating is selected from the group consisting of structural substances occurring in the bone or salts of the bone.
  • 20. The implant according to claim 13 characterized in that the active substance in the coating is present at a concentration that is above the normal physiological blood concentration of that substance.
  • 21. The implant according to claim 13 characterized in that the coating comprises sodium chloride.
  • 22. The implant according to claim 13 characterized in that the coating contains a calcium compound.
  • 23. The implant according to claim 13 characterized in that the coating contains calcium phosphate or calcium sulfate.
  • 24. The implant according to claim 13 characterized in that the coating contains silver in an approximately pure form and this silver has a particle size of 0.001-0.01 micron.
  • 25. The implant according to claim 13 characterized in that the microtherapeutically active substances of the coating are combined with substances having antibiotic activity.
  • 26. The implant according to one of claim 13 characterized in that the coating contains an antibiotic at a concentration selected to inhibit osteonal remodeling.
Priority Claims (1)
Number Date Country Kind
20 2006 006 920.8 Apr 2006 DE national